FDA errs on halting genetic testing

Published: Wednesday, Dec. 11, 2013 - 10:10 am

Re "FDA is correct to halt genetic tests from 23andMe" (Editorials, Dec. 7): The U.S. Food and Drug Administration is busily expanding its power over medical drugs and equipment to include the practice of medicine by individual physicians. The agency's obsession is to make sure that no one is allowed to get well without its permission. One glaring example is the FDA’s legal action against physicians who remove stem cells from a patient to treat that patient. A person's own stem cells are a chemical that only the FDA is permitted to regulate is what the agency is saying in court. For years, the FDA has tried to prevent journals from publishing information about the effectiveness of certain drugs. Now, the FDA pulls the plug using a person's own genetic information. This is about bureaucrats defending their own power, not health care.

-- Richard E. Ralston, Newport Beach, executive director, Americans for Free Choice in Medicine

© Copyright The Sacramento Bee. All rights reserved.

Sacramento Bee Job listing powered by Careerbuilder.com
Quick Job Search
Sacramento Bee Jobs »
Used Cars
Dealer and private-party ads


Price Range:
Search within:
miles of ZIP

Advanced Search | 1982 & Older